Moderna Faces Patent Infringement Allegations Over COVID-19 Vaccine Technology
In a legal development that has captured the attention of the biopharmaceutical sector, Moderna is facing allegations of patent infringement related to the technology utilized in its COVID-19 vaccine. The company is accused of using patented fluorescent protein technology without authorization during various phases of its vaccine development, from preclinical trials to phase III, as…